Clinical trial
A Trial of AXS-05 in Patients With Major Depressive Disorder
NCT04019704
Study timeline
Study start (actual)2019-06-20Date precision: day
Registry last updated2022-10-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Depressionunresolved
Major Depressive Disorderunresolved
Interventions
Sponsors & collaborators
Axsome Therapeutics, Inc.lead sponsor
Mapped research locations
PhoenixArizona, United States2HoustonTexas, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1AtlantaGeorgia, United States1CincinnatiOhio, United States1San DiegoCalifornia, United States1JacksonvilleFlorida, United States1OrlandoFlorida, United States1Oklahoma CityOklahoma, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04019704 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.